Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients

Turk J Gastroenterol. 2016 Mar;27(2):205-6. doi: 10.5152/tjg.2016.160000.
No abstract available

MeSH terms

  • Antiviral Agents / pharmacology*
  • Carbamates / pharmacology*
  • Genotype
  • Hepacivirus / drug effects*
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology
  • Heterocyclic Compounds, 4 or More Rings / pharmacology*
  • Humans
  • Randomized Controlled Trials as Topic
  • Sofosbuvir / pharmacology*

Substances

  • Antiviral Agents
  • Carbamates
  • Heterocyclic Compounds, 4 or More Rings
  • velpatasvir
  • Sofosbuvir